India’s stock markets delivered a classic surprise on August 7, 2025—a volatile “roller coaster” session with sharp intraday swings that caught both bears and bulls off guard. Despite major headwinds from the US announcement of additional tariffs on Indian exports, the Nifty staged a dramatic turnaround, closing higher and showing powerful resilience against global jitters.

Opening Zone:

• Nifty opened with a sharp gap down at 24,464.20, following overnight news of the US doubling tariffs on Indian goods—a move widely expected to trigger sustained selling pressure.
• The index dropped further to an intraday low of 24,344.15, down 200+ points, driven by negative sentiment and global uncertainty.
• By the afternoon, sentiment reversed as strong local buying emerged, propelling Nifty to a session high of 24,634.20.
• Close: Nifty ended at 24,596.15, up by 21.96 points (+0.09%), with volatility (India VIX) down 3.24%.

Why Did the Market Rally Today Despite Tariff Worries?

1. Short Covering and Aggressive Local Buying:
   After the morning sell-off, market participants covering short positions triggered a massive up-move in the afternoon. Domestic institutional investors stepped in heavily, absorbing selling pressure and outmatching bearish bets—especially after key support levels held.
2. “Buy the Fear” Mentality:
   The sharp drop induced panic among sellers, but as global cues stabilized and no further negative developments emerged through the trading day, bargain hunters and algo traders rushed to snap up beaten-down large caps.
3. Sector Resilience:
   • Technology and Pharma stocks were key gainers, with IT majors and select pharma companies leading the bounce, likely driven by defensiveness and less direct tariff exposure.
   • PSE (PSU Enterprises) stocks continued to lag, reflecting policy and export concerns from tariff escalation.
4. Positive Institutional Flows in Second Half:
   Intraday data indicated a meaningful reversal in FII flows and consistent support from domestic players after 1:30PM, fueling the late rally and flipping market sentiment.
5. India’s Domestic Strength:
   News of the RBI holding rates steady and affirming a 6.5% GDP outlook underpinned confidence that the broader macro backdrop remains robust, even amid trade friction headlines.

My  Trades and the Market Mood

• Morning: Buying 24,500 call for ₹60 and selling at ₹75 was prudent as the market looked weak at open.
• Afternoon: Buying the 24,400 call for ₹20 could have yielded exceptional returns as the market soared to a high, underscoring the value of acting on reversal signals and not anchoring to early panic.

Key Technical and Market Points

• Reference levels were less reliable today—with markets staging moves opposite to popular expectations as “ego battles” between global bears and domestic bulls played out.
• Open interest: 24,600 emerged as the key strike with highest OI, acting as a magnet and pivot for today’s wild price action.
• Strategy: Typical short straddle/strangle sellers suffered as realized volatility exceeded implied, while nimble call buyers and reversal traders were rewarded.

Sectoral Movement

• Winners: Technology and pharma, reflecting a search for safety and relative immunity to tariff threats.
• Losers: PSE/PSU stocks, under pressure from trade policy headlines.

Global & Domestic News Drivers

• US Tariff Hike: Trump’s executive order doubling tariffs to 50% on Indian goods sparked the initial sell-off, especially hammering export-oriented sectors.
• India’s Response: Government officials announced moves to diversify export markets and maintain policy stability, buffering market fallout.
• RBI Holds Steady: Central bank kept the repo rate unchanged, with a confidence-inspiring GDP outlook, lending stability late in the day.

Professional Takeaways & Today’s Lesson

• Resilient local buying and aggressive short covering can completely overturn global panic in Indian markets.
• Adaptive traders, who avoid getting stuck in early bias, capture outsized gains during “roller coaster” sessions.
• Sector leaders in technology and pharma can offer safe havens when export-focused and industrial stocks face global headwinds.